Huntington's disease trials in Denmark

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Denmark
  A Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3

  Where

  Copenhagen Oe

  Age

  18 years to 64 years

  People

  60 worldwide

  Run by

  Vico Therapeutics B.V.

  See details and how to join2026-526408-60-00 · EU 2026-526408-60-00
• Phase 3Taking people
  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  Where

  Copenhagen Oe

  Age

  21 years to 70 years

  People

  770 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07326709 · EU 2025-522227-99-00
• Phase 1/2Taking people
  A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

  Where

  Copenhagen Oe

  Age

  25 years to 60 years

  People

  68 worldwide

  Run by

  Vico Therapeutics B. V.

  See details and how to joinNCT05822908 · EU 2024-514328-18-00
• No phaseTaking people
  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  Where

  Aarhus, Copenhagen, Odense

  Age

  18 years and over

  People

  35,000 worldwide

  Run by

  CHDI Foundation, Inc.

  See details and how to joinNCT01574053